Averozolid (IV Infusion)

Anti-infective
Product

Averozolid

Active

Linezolid 200 mg/100ml solution in vial for I.V. Infusion

Category
Anti-infective
Indication

Averozolid is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Averozolid is not indicated for the treatment of Gram negative infections. It is critical that specific Gram-negative therapy be initiated immediately if a concomitant Gram-negative pathogen is documented or suspected.

Dose
 

 

Infection*

 

Dosage , Route and Frequency of Administration

Recommended Duration of Treatment ( consecutive days)

Pediatric Patients ( Birth through 11 Years of Age ) Adults and Adolescents ( 12 Years and Older )
Nosocomial pneumonia  

 

10 mg / kg intravenously every 8 hours

 

 

600 mg intravenously every 12 hours

 

 

 

10 to 14

 

Community acquired pneumonia , including concurrent bacteremia
Complicated skin and skin structure infections
Vancomycin resistant Enterococcus faecium infections , including concurrent bacteremia 10 mg / kg intravenously every 8 hours 600 mg intravenously every 12 hours  

14 to 28